Rhodamine B: A recent ban issued by the Food and Drug Administration (FDA) in January 2025 further reinforces these restrictions, prohibiting the use of Rhodamine B in any food-related applications due to increasing evidence of its carcinogenic properties.
o Carcinogenic Risk: Due to DNA damage and oxidative stress.
o Vulnerable Groups: Children, elderly, and immunocompromised individuals.
o Skin Reactions: Allergies, redness, pigmentation changes with long-term exposure.